Genetic damage detected in CD‐1 mouse pups exposed perinatally to 3′‐azido‐3′‐deoxythymidine and dideoxyinosine via maternal dosing, nursing, and direct gavage
Authors:
- 16 January 2004
- journal article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 43 (1) , 3-9
Abstract
Human immunodeficiency virus (HIV)‐infected pregnant women are administered nucleoside‐analogue antiretrovirals to reduce maternal‐infant viral transmission. The current protocol recommends treating newborns for 6 additional weeks postpartum. The treatment is effective, but the risk of drug‐induced chromosomal damage in neonates remains undefined. We used a mouse model to investigate this concern. In a multigeneration reproductive toxicity study, female CD‐1 mice received 3′‐azido‐3′‐deoxythymidine (AZT) and dideoxyinosine (ddI) (50/250, 75/375, 150/750 mg/kg/day AZT/ddI) by gavage twice daily in equal fractions beginning prior to mating and continuing throughout gestation and lactation. Direct pup dosing (same regimen) began on postnatal day (PND) 4. Peripheral blood erythrocytes of male pups were screened for micronuclei, markers of chromosomal damage, on PNDs 1, 4, 8, and 21. Extraordinary increases in micronucleated cells were noted in pups for each treatment group at each sampling time; treated dams exhibited smaller yet significant increases in micronucleated erythrocytes. The frequencies of micronucleated cells in untreated pups were higher than in the untreated dams, and all pups had markedly elevated levels of circulating reticulocytes compared to dams. These observations suggest that fetal and neonatal mouse hematopoietic precursor cells have heightened sensitivity to genotoxic agents, perhaps due to rapid cell proliferation during the perinatal period of development. The amount of genetic damage observed in treated pups raises concern for the potential of similar damage in humans. Investigations of chromosomal integrity in exposed newborns and children are recommended. Environ. Mol. Mutagen. 43:3–9, 2004.Keywords
This publication has 31 references indexed in Scilit:
- Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infantsAIDS, 2003
- Antiretroviral Therapy Effects on Genetic and Morphologic End Points in Lymphocytes and Sperm of Men with Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2001
- Incorporation of 3´-Azido-3´-Deoxythymidine (AZT) Into Fetal DNA and Fetal Tissue Distribution of Drug After Infusion of Pregnant Late-Term Rhesus Macaques With a Human-Equivalent AZT DoseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Multiorgan Transplacental and Neonatal Carcinogenicity of 3′-Azido-3′-deoxythymidine in MiceToxicology and Applied Pharmacology, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994
- Prior bleeding enhances the sensitivity of the in vivo micronucleus testMutation Research Letters, 1991
- Induction of micronuclei in mouse bone marrow cells: An evaluation of nucleoside analogues used in the treatment of AIDSEnvironmental and Molecular Mutagenesis, 1991
- The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studiesFundamental and Applied Toxicology, 1990
- Kinetics of micronucleus formation in relation to chromosomal aberrations in mouse bone marrowMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1984
- The persistence of micronuclei in peripheral blood erythrocytes: detection of chronic chromosome breakage in miceMutation Research Letters, 1982